The Effect of Skin-to-skin Contact on Placental Separation Time, Type, Postpartum Hemorrhage and Comfort
NCT ID: NCT06011096
Last Updated: 2023-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
126 participants
INTERVENTIONAL
2022-11-02
2023-08-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Skin-to-Skin Contact Applied in the Early Postpartum Period on Maternal Pain, Birth Satisfaction, and Maternal Vital Signs Dynamics
NCT07304037
Skin-to-Skin Contact With a Sling in Primipar Mothers Who Delivered by Cesarean Section
NCT06502860
The Effect of Paternal Skin-to-Skin Contact on Neonatal Parameters
NCT06956859
Multıdımensıonal Effects Of Delayed Cord Clampıng and Mılkıng on Placental Processes
NCT06865391
The Effect of Facilitated Tucking After Vaginal Delivery on Late Preterm Stress, Comfort and Physiological Parameters
NCT05430321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
control group
* Pregnant women who met the criteria for admission to the delivery room were selected, the institution's routine policies were implemented.
* The mother was informed about the study and written consent was obtained.
* Hospital routine practices continued until birth.
* The stopwatch is started the moment the baby is born.
* After birth, the umbilical cord was clamped immediately without skin-to-skin contact between the mother and the baby, and the baby was taken to routine care.
* Signs of placental separation were monitored with a stopwatch, and it was noted at what minute the symptoms were seen.
* Placental delivery time and separation type were noted in the relevant part of the form.
* According to the routines taken from each hospitalized patient in institutional policies, the volunteer's entry hemoglobin and hematocrit values were noted on the form.
* The Personal Information Form consisting of 22 questions and the Postpartum Comfort scale were administered to the mother at the end of the follow-up period in the delivery room (2 hours later).
* From the 6th hour blood values found in the hospital routine, the mother's hemoglobin and hematocrit values were noted on the form.
Experimental group
* Pregnant women who met the criteria for admission to the delivery room were selected, the institution's routine policies were implemented.
* The mother was informed about the study and written consent was obtained.
* Hospital routine practices continued until birth.
* The stopwatch is started the moment the baby is born.
* The baby was placed on the mother's chest, it was waited for 60-90 seconds in skin-to-skin contact, and breastfeeding was tried. At the end of the period, the umbilical cord was clamped and the baby was placed under a radiant heater and routine care was continued.
* Signs of placental separation were monitored with a stopwatch, and it was noted at what minute the symptoms were seen.
* Placental delivery time and separation type were noted in the relevant part of the form.
* According to the routines taken from each hospitalized patient in institutional policies, the volunteer's entry hemoglobin and hematocrit values were noted on the form.
* During the repair of episiotomy or desuria, if any, in the mother, skin-to-skin contact was made between the baby and the mother for 1 hour without disrupting the procedures.
* The Personal Information Form consisting of 22 questions and the Postpartum Comfort scale were administered to the mother at the end of the follow-up period in the delivery room (2 hours later).
* From the 6th hour blood values found in the hospital routine, the mother's hemoglobin and hematocrit values were noted on the form.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the group with skin-to-skin contact and delayed cord clamping
In this arm, skin-to-skin contact and delayed cord clamping are performed between mother and baby.
skin-to-skin contact and delayed cord clamping
Placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated with skin-to-skin contact and late cord clamping after delivery.
The group without skin-to-skin contact and early cord clamping
In this arm, skin-to-skin contact and delayed cord clamping are not performed between mother and baby.
avoiding skin-to-skin contact and early cord clamping
After delivery, placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated without skin-to-skin contact and late cord clamping.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
skin-to-skin contact and delayed cord clamping
Placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated with skin-to-skin contact and late cord clamping after delivery.
avoiding skin-to-skin contact and early cord clamping
After delivery, placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated without skin-to-skin contact and late cord clamping.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Those who agreed to participate in the research
2. 18-49 years old
3. Firstborn (nulliparous)
4. Have 37-42 weeks of pregnancy
5. The baby in head presentation
6. No prenatal risk pregnancy
7. No risk during and after birth
* for newborns
1. Absence of any health problems or congenital diseases,
2. No need for resuscitation after birth.
3. APGAR score of 8 points or more
Exclusion Criteria
2. Multiparity
3. Any complications in the mother or baby
4. Removal of the placenta by intervention rather than spontaneous separation
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bahar GÖBEL
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bahar GÖBEL
Midwife
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bahar Göbel
Role: PRINCIPAL_INVESTIGATOR
Midwife
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erzurum City Hospital
Erzurum, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Erzurum Atatürk Üniversitesi
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.